{
    "eid": "2-s2.0-84967157533",
    "title": "Gene therapies in clinical trials",
    "cover-date": "2016-01-11",
    "subject-areas": [],
    "keywords": [
        "CRISPR",
        "Gene editing",
        "Gene therapy",
        "IPSC",
        "Nucleases",
        "Personalized medicine",
        "RNAi",
        "Stem cells"
    ],
    "authors": [
        "Konstantinos I. Papadopoulos"
    ],
    "citedby-count": 10,
    "ref-count": 163,
    "ref-list": [
        "Discovering DNA: Friedrich Miescher and the early years of nucleic acid research",
        "Molecular structure of nucleic acids: A structure for deoxyribose nucleic acid",
        "Nature: News Explainer",
        "Endgame: Glybera finally recommended for approval as the first gene therapy drug in the European union",
        "Milestone approval lifts Illumina's NGS from research into clinic.",
        "History of gene therapy",
        "The hope, hype & reality of genetic engineering: remarkable stories from agriculture, industry, medicine, and the environment",
        "Identification of sequence variants in genetic disease-causing genes using targeted next-generation sequencing",
        "Initial impact of the sequencing of the human genome",
        "State-of-the-art human gene therapy: Part II. gene therapy strategies and clinical applications",
        "Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial",
        "Retinal gene therapy in patients with choroideremia: Initial fi ndings from a phase 1/2 clinical trial",
        "Recent developments in the treatment of age-related macular degeneration",
        "Promising and delivering gene therapies for vision loss",
        null,
        "Transduction of photoreceptors with equine infectious anemia virus lentiviral vectors: Safety and biodistribution of stargen for stargardt disease",
        "Non-syndromic retinal ciliopathies: Translating gene discovery into therapy",
        "Combination of retinitis pigmentosa and hearing loss caused by a novel mutation in PRPH2 and a known mutation in GJB2: Importance for differential diagnosis of Usher syndrome",
        "AAV-mediated knockdown of Peripherin-2 in vivo using miRNA-based hairpins",
        "Gene therapy for PRPH2-Associated ocular disease: Challenges and prospects",
        "Comprehensive molecular diagnosis of 179 Leber congenital amaurosis and juvenile retinitis pigmentosa patients by targeted next generation sequencing",
        "Synthesis of monodisperse biotinylated p(NIPAAm)-coated iron oxide magnetic nanoparticles and their bioconjugation to streptavidin",
        "Cationic glyco-functionalized single-walled carbon nanotubes as efficient gene delivery vehicles",
        "The effect of polymer architecture, composition, and molecular weight on the properties of glycopolymer-based non-viral gene delivery systems",
        "Well-controlled cationic water-soluble phospholipid polymerDNA nanocomplexes for gene delivery",
        "Synthesis of cationic magnetic nanoparticles and evaluation of their gene delivery efficacy in Hep G2 cells",
        "The effect of molecular weight, compositions and lectin type on the properties of hyperbranched glycopolymers as non-viral gene delivery systems",
        "Impact of the nature, size and chain topologies of carbohydrate-phosphorylcholine polymeric gene delivery systems",
        "Prog Polym Sci",
        "Biodegradable and nontoxic nanogels as nonviral gene delivery systems",
        "Cationic glyco-nanogels for epidermal growth factor receptor (EGFR) specific siRNA delivery in ovarian cancer cells",
        "Gene therapy for hemophilia",
        "Delivery of full-length factor VIII using a piggyBac transposon vector to correct a mouse model of hemophilia A",
        "Developments in the treatment of hemophilia B: Focus on emerging gene therapy",
        "Long-term safety and efficacy of factor IX gene therapy in hemophilia B",
        "Moving forward: Cystic fibrosis gene therapy",
        "A modified \u03b3-retrovirus vector for X-linked severe combined immunodeficiency",
        "Update on gene therapy for immunodeficiencies",
        "Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: Clinical comparison of retroviral vectors and treatment plans",
        "Lentiviral hematopoietic stem cell gene therapy in patients with wiskott-aldrich syndrome",
        "An AAVS1-targeted minigene platform for correction of iPSCs from all five types of chronic granulomatous disease",
        "Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy",
        "Gene therapy as a new treatment option for inherited monogenic diseases",
        "Developing therapeutic approaches for metachromatic leukodystrophy",
        "The prevalence of \u03b2-thalassemia mutations in south western Maharashtra",
        "Gene therapy for hemoglobinopathies: The state of the field and the future",
        "Transfusion independence and HMGA2 activation after gene therapy of human \u03b2-thalassaemia",
        "Gene therapy for primary immunodeficiencies: Part 1",
        "Generation of human \u03b2-thalassemia induced pluripotent cell lines by reprogramming of bone marrow-derived mesenchymal stromal cells using modified mRNA",
        "Gene therapy delivery systems for enhancing viral and nonviral vectors for cardiac diseases: Current concepts and future applications",
        "Gene therapy finds its niche",
        "Secondary malignancies following high dose therapy and autologous hematopoietic cell transplantation-systematic review and meta-analysis",
        "Cancer immunotherapy utilizing gene-modified T cells: From the bench to the clinic",
        "J Genet Syndr Gene Ther",
        "Engineering HSV-1 vectors for gene therapy",
        "J Cancer Res Ther (Manch)",
        "Gene Therapy for the Nervous System: Challenges and New Strategies",
        "J Clin Oncol",
        "Chimeric antigen receptor T-cell therapy to target hematologic malignancies",
        "Antibody-modified T cells: CARs take the front seat for hematologic malignancies",
        "A closer look at chimeric antigen receptor specificity",
        "Cardiovascular gene therapy for myocardial infarction",
        "Long-term effects of AAV1/SERCA2a gene transfer in patients with severe heart failure: Analysis of recurrent cardiovascular events and mortality",
        "Gene therapy in heart failure. SERCA2a as a therapeutic target",
        "Design of a Phase 2b Trial of Intracoronary Administration of AAV1/SERCA2a in Patients With Advanced Heart Failure. The CUPID 2 Trial (Calcium Up-Regulation by Percutaneous Administration of Gene Therapy in Cardiac Disease Phase 2b)",
        "Functional polymers of gene delivery for treatment of myocardial infarct",
        "Gene therapy to stimulate angiogenesis to treat diffuse coronary artery disease",
        "Int J Mol Cell Med",
        "RNA interference therapy: A new solution for intracranial atherosclerosis?",
        "Nanoparticle drug- and gene-eluting stents for the prevention and treatment of coronary restenosis",
        "HCN2/SkM1 gene transfer into canine left bundle branch induces stable, autonomically responsive biological pacing at physiological heart rates",
        "Human Mesenchymal Stem Cells as a Gene Delivery System to Create Cardiac Pacemakers",
        "Gene therapy and cell-based therapies for therapeutic angiogenesis in peripheral artery disease",
        "Clinical effectiveness of gene therapy on critical limb ischemia: A meta-analysis of 5 randomized controlled clinical trials",
        "Assessment of chondrogenic differentiation potential of autologous activated peripheral blood stem cells on human early osteoarthritic cancellous tibial bone scaffold",
        "Use of Tissue Engineering Strategies to Repair Joint Tissues in Osteoarthritis: Viral Gene Transfer Approaches",
        "Co-transduction of lentiviral and adenoviral vectors for co-delivery of growth factor and shRNA genes in mesenchymal stem cells-based chondrogenic system",
        "SOX trio-co-transduced adipose stem cells in fibrin gel to enhance cartilage repair and delay the progression of osteoarthritis in the rat"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Edmonton",
            "affilname": "University of Alberta",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "THAI StemLife",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}